ImmuneOnco Biopharmaceuticals (Shanghai) Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 1 | 2 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 |
Disease areas by active trials, top 10 of 11
Liver Cancer (2) · Breast Cancer (1) · Follicular Lymphoma (1) · Heart Disease (1) · Hodgkin Lymphoma (1) · Leukemia (1) · Lung Cancer (1) · MDS/MPN Overlap (1) · Non-Hodgkin Lymphoma (1) · Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.